Ya-Ping Guo

Ya-Ping Guo

Auto-generated profile, based on publicly available information

Ya-Ping Guo

The Education Ministry Key Lab of Resource Chemistry and Shanghai Key Laboratory of Rare Earth Functional Materials, Shanghai Normal University, Shanghai 200234, China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2016 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
STShi-Cong Tao
Shi-Cong Tao
SGShang-Chun Guo
Shang-Chun Guo
MLMin Li
Min Li
QKQin-Fei Ke
Qin-Fei Ke
YGYa-Ping Guo
Ya-Ping Guo
CZChangqing Zhang
Changqing Zhang
There is a need to find better strategies to promote wound healing, especially of chronic wounds, which remain a challenge. We found that synovium mesenchymal stem cells (SMSCs) have the ability to strongly promote cell proliferation of fibroblasts; however, they are ineffective at promoting angiogenesis. Using gene overexpression technology, we overexpressed microRNA-126-3p (miR-126-3p) and transferred the angiogenic ability of endothelial progenitor cells to SMSCs, promoting angiogenesis. We tested a therapeutic strategy involving controlled-release exosomes derived from miR-126-3p-overexpressing SMSCs combined with chitosan. Our in vitro results showed that exosomes derived from miR-126-3p-overexpressing SMSCs (SMSC-126-Exos) stimulated the proliferation of human dermal fibroblasts and human dermal microvascular endothelial cells (HMEC-1) in a dose-dependent manner. Furthermore, SMSC-126-Exos also promoted migration and tube formation of HMEC-1. Testing this system in a diabetic rat model, we found that this approach resulted in accelerated re-epithelialization, activated angiogenesis, and promotion of collagen maturity in vivo. These data provide the first evidence of the potential of SMSC-126-Exos in treating cutaneous wounds and indicate that modifying the cells—for example, by gene overexpression—and using the exosomes derived from these modified cells provides a potential drug delivery system and could have infinite possibilities for future therapy.

1 July 2017 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
MLMin Li
Min Li
BLBin Lu
Bin Lu
QKQin-Fei Ke
Qin-Fei Ke
YGYa-Jun Guo
Ya-Jun Guo
YGYa-Ping Guo
Ya-Ping Guo

1 March 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
YLYong Lei
Yong Lei
ZXZhengliang Xu
Zhengliang Xu
QKQinfei Ke
Qinfei Ke
WYWenjing Yin
Wenjing Yin
YCYixuan Chen
Yixuan Chen
YGYaping Guo
Yaping Guo

23 September 2016 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
MLMin Li
Min Li
QKQin-Fei Ke
Qin-Fei Ke
STShi-Cong Tao
Shi-Cong Tao
SGShang-Chun Guo
Shang-Chun Guo
BRBi-Yu Rui
Bi-Yu Rui
YGYa-Ping Guo
Ya-Ping Guo
The exploration of an effective diabetic chronic wound healing process still remains a great challenge. Herein, we used gene overexpression technology to obtain synovial mesenchymal stem cells (SMSCs) and the miR-126-3p highly expressed SMSCs (SMSCs-126). The exosomes derived from miR-126-3p overexpressed SMSCs (SMSCs-126–Exos) with a particle size of 85 nm were encapsulated in hydroxyapatite/chitosan (HAP–CS) composite hydrogels (HAP–CS–SMSCs-126–Exos) as wound dressings. The SMSCs-126–Exos, CS and low-crystallinity HAP nanorods with a length of 200 nm and a diameter of 50 nm are uniformly dispersed within the whole composite hydrogel. The HAP–CS–SMSCs-126–Exos possess the controlled release property of SMSCs-126–Exos for at least 6 days. The released SMSCs-126–Exos nanoparticles stimulate the proliferation and migration of human dermal fibroblasts and human dermal microvascular endothelial cells (HMEC-1). At the same time, the migration and capillary-network formation of HMEC-1 are promoted through the activation of MAPK/ERK and PI3K/AKT. In vivo tests demonstrate that the HAP–CS–SMSCs-126–Exos successfully promote wound surface re-epithelialization, accelerate angiogenesis, and expedite collagen maturity due to the presence of HAP, CS and SMSCs-126–Exos. Therefore, the HAP–CS–SMSCs-126–Exos possess great potential application for diabetic chronic wound healing, and especially provide the possibility of using exosomes derived from modified cells as a new approach to bring wonderful functionality and controllability in future chronic wound therapy.

1 January 2011 in Chemical Engineering Journal
Verified
Journal Article
Closed access
YGYa-Ping Guo
Ya-Ping Guo
HWHai-Jin Wang
Hai-Jin Wang
YGYa-Jun Guo
Ya-Jun Guo
LGLi-Hua Guo
Li-Hua Guo
LCLian-Feng Chu
Lian-Feng Chu
CGCui-Xiang Guo
Cui-Xiang Guo

1 April 2018 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
JLJia-Wei Lu
Jia-Wei Lu
FYFan Yang
Fan Yang
QKQin-Fei Ke
Qin-Fei Ke
XXXue-Tao Xie
Xue-Tao Xie
YGYa-Ping Guo
Ya-Ping Guo